Archive summary
InvestorNewsBreaks – Helus Pharma(TM) (NASDAQ: HELP) (Cboe CA: HELP) CEO Steps Down, Eric So Named Interim Chief Executive Office
This article has been disseminated on behalf of Helus Pharma and may include paid advertising.
Index
All articles
Every article on TheraNews, newest first.
4,073 articles · page 30 of 102 · Apr 19, 2026 – Apr 21, 2026
Archive summary
Long COVID depression: How the virus can also impact mental health
COVID can take a physical toll. However, a family medicine physician from Baylor Scott and White in Temple explains how the virus' lingering aftereffects can impact…
Archive summary Clinical
Merck and Eisai Provide Update on Phase 3 LITESPARK-012 Trial Evaluating First-Line Combination Treatments for Certain Patients With Advanced Renal Cell Carcinoma (RCC)
RAHWAY, N.J. & NUTLEY, N.J.--(BUSINESS WIRE)--Apr 21, 2026--
Archive summary Clinical
Moonbird Claims Evaluated: Guided Breathing Therapy Device For Meditation-Like Calming Benefits For Relaxation & Sleep Support
A 2026 informational overview of Moonbird's tactile breathing coach technology, EEG brain scan research references, real-time HRV biofeedback, pricing structure, ...
Archive summary Clinical
Opinion: The contradiction at the heart of Republicans’ embrace of psychedelics
“The research is clear about one thing: Recovery is not primarily a pharmacological event,” write Dimitri Mugianis and Ross Ellenhorn.
Archive summary
Optum Expands TMS Policy to Include Nurse Practitioners
MALVERN, PA — Neuronetics, Inc. (Nasdaq: STIM) said Optum, UnitedHealthcare, and United Behavioral Health recently updated a clinical policy to allow psychiatric mental…
Archive summary
PharmaTher Highlights Strategic Ketamine Opportunity Following New U.S. Executive Order on Psychedelic Treatments for Serious Mental Illness
Company believes supportive U.S. policy momentum may strengthen the strategic value of its ketamine patch, KetaVaultTM platform, retained ketamine programs, and prior…
Archive summary Clinical
Psychedelic drug stocks soar as Trump fast‐tracks FDA reviews
Shares of psychedelic drug developers rose after Trump signed an executive order directing health regulators to speed up reviews of treatments.
Archive summary
PsychedelicNewsBreaks – Helus Pharma(TM) (NASDAQ: HELP) (Cboe CA: HELP) Supports Executive Order Advancing Psychedelic Therapies
This article has been disseminated on behalf of Helus Pharma and may include paid advertising.
Archive summary
Psychedelics May Soon Become Easier to Get. Is That Good?
More and more research is being done on psychedelics including LSD, psilocybin, and ibogaine. Now, the government wants to make them more available. Discover the…
Archive summary Clinical
Small-Cap Medical Stocks: ATAI, CMPS, NDRA, PBM in Focus as U.S. Policy Accelerates Psychedelic Research
A renewed spotlight is forming around a group of small-cap healthcare companies as U.S. policy shifts toward accelerating research into psychedelic-based therapies for…
Archive summary
The Chains: Mapping pharmacy’s landscape
From national chains to community-based networks, pharmacy operators are adapting to regulatory changes while boosting investments in clinical care, technology, and…
Archive summary
Vaccinations urged as dangerous strain of mpox virus emerges in Northern California
Health officials urge at-risk residents to get vaccinated immediately.
Archive summary Policy
Weight Watchers Appoints Proven Healthcare Executive Heather Thiltgen to Board of Directors
NEW YORK, April 20, 2026 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ: WW ) ("Weight Watchers" or the "Company"), the global leader in science-backed weight…
Archive summary
3 red flags that you’re headed for insomnia — from mood swings to micro-sleeps
"You don’t measure sleep health by time in bed, you measure it by daytime function" — the signs to look for during the day that can help you recognize problems at night.
Archive summary Policy
CCHR Says New OIG Report Exposes Repeat of 20-Year-Old Findings: U.S. Nursing Homes Drugging Elderly with Antipsychotics
April 20, 2026 -- Vulnerable elderly residents face serious risks and premature death from antipsychotics, as nursing homes and their prescribers evade meaningful…
Archive summary Clinical
Compass Pathways to Participate in Needham Virtual Psychedelics Forum on April 27, 2026
LONDON & NEW YORK--(BUSINESS WIRE) $CMPS Biotech--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based…
Archive summary Policy
FDA Policy Tracker 2026: Psychedelics get a boost
A year of significant policy change at the FDA brought momentum and scrutiny into the new year. As 2026 gets underway, biopharma companies are responding to sweeping…
Archive summary
Helus Pharma Announces Chief Executive Officer Transition; Eric So to Resume Role as Interim Chief Executive Officer
Helus Pharma announced that Chief Executive Officer Michael Cola is stepping down effective immediately at the request of the Board of Directors. Co-founder and…
Archive summary
Home Health’s Hidden Collapse: Baby Boomers’ Care Crisis Fuels Labor Market Warning Signs
Home healthcare buckles as baby boomers age, with plunging hours, 80% turnover, and immigrant curbs worsening shortages. Low wages fuel exits, risking unpaid care…
Archive summary
How to manage sleep apnea while traveling —experts share what to prep and pack
Everything you need to know about managing sleep apnea while travelling, including an expert-approved packing list.
Archive summary Clinical
NRx Pharmaceuticals (Nasdaq:NRXP) Welcomes Presidential Initiative to Accelerate Approval of Psychedelic Medications to Treat Depression, PTSD, and Suicidality
WILMINGTON, Del., April 20, 2026 (GLOBE NEWSWIRE) -- NRx Pharmaceuticals (Nasdaq:NRXP) welcomes the newly-signed Executive Order: ACCELERATING MEDICAL TREATMENTS FOR…
Archive summary Clinical
Numinus Wellness Responds To Trump Executive Order On Psychedelic Therapies
Numinus Wellness Responds to Trump Executive Order on Psychedelic Therapies Company's clinical research operations and therapist training programs directly positioned to…
Archive summary
Optimi Health Launches Ibogaine Initiative as U.S. Executive Order Signals Pathway for Psychedelic Drug Products
The Company's Health Canada-licensed GMP psychedelic manufacturing platform ready to serve emerging demand for ibogaine, a naturally occurring alkaloid under…
Archive summary
Precipio (NASDAQ:PRPO) & Talkspace (NASDAQ:TALK) Financial Analysis
Precipio (NASDAQ:PRPO – Get Free Report) and Talkspace (NASDAQ:TALK – Get Free Report) are both small-cap medical companies, but which is the better investment? We will…
Archive summary Clinical
StockWatch: Revolution’s Phase III Pancreatic Cancer Data Dazzles Investors, Analysts
In the trial’s overall (intent-to-treat) study population, daraxonrasib showed a median overall survival (OS) of 13.2 months, nearly double the 6.7 months demonstrated…
Archive summary
Texas will launch its own clinical trials into ibogaine psychedelic after failing to find a drug company
The state’s effort will get a boost from the federal government thanks to a new executive order from President Donald Trump.
Archive summary
The marijuana of my youth is long gone. I wish someone had told me
Marijuana legalization is growing — and so is the potency of today’s weed. It’s a lesson this reporter learned the hard way.
Archive summary Clinical
They tried everything, and nothing worked. Now, women are turning to cannabis for help
The latest chapter in Dr. Sanjay Gupta’s “Weed” documentary showed him that cannabis has become a lifeline for countless women who feel unseen by...
Archive summary
Trump Administration Accelerates Psychedelic Research for Mental Health Treatments
President Donald Trump signs an executive order to fast-track studies on the use of psychedelic drugs for depression, PTSD, addiction, and other mental health…
Archive summary
Trump-backed plan could fast-track psychedelic therapies — here’s what to know
President Trump has signed an executive order to fast-track psychedelic research and FDA approval, sparking debate among doctors over safety and mental health benefits.
Archive summary
WA police lag on required deescalation, mental health training
Washington law enforcement officers are way behind completing deescalation and mental health training required under the state’s marquee police accountability law.
Archive summary
WATCH: Trump signs executive order speeding up research on using psychedelics for mental health
'Will ensure that people suffering from debilitating symptoms might finally have a chance to reclaim their lives and lead a happier life'
Archive summary
What will new Western State Hospital look like?
As construction on the new $947 million Western State Hospital Facility continues in Lakewood, the state Department of Social and Health Services gave an update to the…
Archive summary
With pediatric expansion, Urban Indian Center of Salt Lake clinic breaks record number of patients
Historically, the clinic at the Urban Indian Center of Salt Lake, a health and wellness institution for Native Americans living off-reservation, mostly focused on…
Archive summary Clinical
Xenon Presents Azetukalner Phase 3 X-TOLE2 Study Results and 48-Month Long-term Data in Focal Onset Seizures at 2026 AAN Annual Meeting
Azetukalner data show significant reductions in seizure frequency across weekly, monthly and multi-year time points X-TOLE2 data featured in Late-breaking Science…
Archive summary Clinical
A look at the ‘Wild West’ of synthetic kratom, which doctors are calling ‘more potent than fentanyl’
Since 2015, kratom poisonings have surged by 1,200%, according to a recent report.
Archive summary Clinical
Compass Pathways Commends White House Executive Order to Accelerate Research and Access for Psychedelic Treatments
Archive summary
HSS Presents New Research Leveraging AI to Uncover Insights Related to Pain Risk and Anesthesia Education at ASRA Annual Meeting
PHOENIX--(BUSINESS WIRE)--At this year’s American Society of Regional Anesthesia and Acute Pain Medicine (ASRA) annual meeting, investigators at Hospital for Special…
Archive summary
Joe Rogan Joins Trump for Signing of EO to Fast-Track Access to Psychedelic Drug-Based Research, Treatment
Source of breaking news and analysis, insightful commentary and original reporting, curated and written specifically for the new generation of independent and…